1
He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao: Quinolones with anti-hiv activity. Irm, He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037853 (12 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using quinolones and compounds related to quinolones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of proph ...


2
Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao: Pyrrolidones with anti-hiv activity. Irm, Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037784 (6 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of p ...


3
He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry: Oxindoles with anti-hiv activity. Irm, The Scripps Research Institute, He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry, FITTING Thomas, May 6, 2004: WO/2004/037247 (2 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using oxindoles and compounds related to oxindoles. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of prophyl ...


4

5
Caldwell Jeremy, Nguyen Deborah, Kuhen Kelli L: Methods for identifying compounds that inhibit hiv infection. Irm, October 24, 2007: EP1846580-A2

This invention provides novel methods for identifying agents that inhibit HIV infection. The anti-HIV agents are identified by screening test compounds for ability to down-regulate the kinase activity or the expression of a PAK3 molecule. Such PAK3 modulators can be further examined for their activi ...


6
Kuhen Kelli L, Caldwell Jeremy S: Methods and compositions for inhibiting hiv infection using agents that modulate isopeptidase t activity. Irm, January 23, 2008: EP1880212-A2

This invention provides novel methods for identifying agents that inhibit HIV infection. The anti-HIV agents are identified by screening test compounds for ability to modulate a biological activity of isopeptidase T (IsoT), e.g., its isopeptidase activity or its binding to another molecule such as v ...


7
Nguyen Deborah, Kuhen Kelli L, Caldwell Jeremy: Methods and compositions for inhibiting hiv infection. Irm, Nguyen Deborah, Kuhen Kelli L, Caldwell Jeremy, REID Scott W, June 14, 2007: WO/2007/067737

This invention provides novel HIV-interacting host factors. The invention also provides methods of using the HIV-interacting host factors to screen for compounds that inhibit HIV infection. The methods comprise first screening test compounds for modulators of an HIV-interacting host factor disclosed ...


8
Caldwell Jeremy, Nguyen Deborah, Kuhen Kelli L: Methods for identifying compounds that inhibit hiv infection. Irm, Caldwell Jeremy, Nguyen Deborah, Kuhen Kelli L, WANG Hugh, December 14, 2006: WO/2006/132681

This invention provides novel methods for identifying agents that inhibit HIV infection. The anti-HIV agents are identified by screening test compounds for ability to down-regulate the kinase activity or the expression of a PAK3 molecule. Such PAK3 modulators can be further examined for their activi ...


9
Kuhen Kelli L, Caldwell Jeremy S: Methods and compositions for inhibiting hiv infection using agents that modulate isopeptidase t activity. Irm, Kuhen Kelli L, Caldwell Jeremy S, WANG Hugh, November 2, 2006: WO/2006/116075

This invention provides novel methods for identifying agents that inhibit HIV infection. The anti-HIV agents are identified by screening test compounds for ability to modulate a biological activity of isopeptidase T (IsoT), e.g., its isopeptidase activity or its binding to another molecule such as v ...


10
Nguyen Deborah, Kuhen Kelli L, Caldwell Jeremy: Methods and compositions for inhibiting hiv infection. Irm, September 5, 2008: KR1020087013695

This invention provides novel HIV-interacting host factors. The invention also provides methods of using the HIV-interacting host factors to screen for compounds that inhibit HIV infection. The methods comprise first screening test compounds for modulators of an HIV-interacting host factor disclosed ...